BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28881915)

  • 21. Chronic myeloid leukaemia.
    Apperley JF
    Lancet; 2015 Apr; 385(9976):1447-59. PubMed ID: 25484026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report.
    Costello RT; Gabert J; Brunel V; Sainty D; Arnoulet C; Mozziconacci MJ; Camerlo J; Perret C; Gastaut JA; Bouabdallah R
    Br J Haematol; 1995 Oct; 91(2):428-30. PubMed ID: 8547089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Simonsson B
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii51-2. PubMed ID: 17491046
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Chronic myeloid leukaemia presenting as priapism in children: need for multidisciplinary approach.
    Nabi G; Dogra PN
    East Afr Med J; 2000 Oct; 77(10):576. PubMed ID: 12862132
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chronic myeloid leukemia. Diagnosis, treatment].
    Guilhot F
    Rev Prat; 1993 Nov; 43(17):2263-8. PubMed ID: 8146549
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chronic myeloid leukemia--contemporary diagnosis and treatment possibilities].
    Goździk J; Hansz J
    Pol Arch Med Wewn; 2001; 105 Suppl():391-4. PubMed ID: 12412274
    [No Abstract]   [Full Text] [Related]  

  • 27. The chronic myeloid leukaemia story in the United Kingdom since 1960.
    Clark RE
    Br J Haematol; 2020 Nov; 191(4):521-526. PubMed ID: 33190253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guideline for management of chronic myeloid leukemia(2013)].
    Chinese Society of Hematology, Chinese Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):464-70. PubMed ID: 23688765
    [No Abstract]   [Full Text] [Related]  

  • 29. Another set of guidelines for chronic myeloid leukaemia.
    Clark RE
    Br J Haematol; 2020 Oct; 191(2):147-149. PubMed ID: 32712951
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia].
    Rejtó L; Balázs M; Adány R; Rák K; Telek B; Kiss A; Ujj G; Mezei G; Balogh E; Udvardy M
    Orv Hetil; 2000 Sep; 141(39):2133-7. PubMed ID: 11028176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?
    Gale RP; Apperley J
    Curr Hematol Malig Rep; 2019 Dec; 14(6):477-479. PubMed ID: 31858440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.
    Radich JP; Deininger M; Abboud CN; Altman JK; Berman E; Bhatia R; Bhatnagar B; Curtin P; DeAngelo DJ; Gotlib J; Hobbs G; Jagasia M; Kantarjian HM; Maness L; Metheny L; Moore JO; Pallera A; Pancari P; Patnaik M; Purev E; Rose MG; Shah NP; Smith BD; Snyder DS; Sweet KL; Talpaz M; Thompson J; Yang DT; Gregory KM; Sundar H
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1108-1135. PubMed ID: 30181422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma.
    Mughal TI; Goldman JM
    Eur J Cancer; 2001 Mar; 37(5):561-8. PubMed ID: 11290430
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Alyea EP; Soiffer RJ; Roy DC; Ritz J
    Blood; 1994 Oct; 84(7):2109-14. PubMed ID: 7919323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring minimal residual disease in chronic myeloid leukemia: fluorescence in situ hybridization and polymerase chain reaction.
    Hughes TP; Branford S
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S266-71. PubMed ID: 19778851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias.
    Spiers AS
    Hematology; 2002 Feb; 7(1):1-8. PubMed ID: 12171771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
    Romzova M; Smitalova D; Hynst J; Tom N; Loja T; Herudkova Z; Jurcek T; Stejskal L; Zackova D; Mayer J; Racil Z; Culen M
    Br J Haematol; 2021 Aug; 194(3):604-612. PubMed ID: 34212373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The present status and prospect of diagnosis and treatment of chronic myelogenous leukemia in China].
    Jiang Q; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2013 Oct; 52(10):803-5. PubMed ID: 24378053
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC
    Hematol Cell Ther; 1998 Oct; 40(5):224-8. PubMed ID: 9844816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.